Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Proguanil hydrochloride+chloroquine phosphate |
Is a |
Medicinal product containing aminoquinoline and acting as antimalarial agent (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
Is a |
Medicinal product containing biguanide and acting as antimalarial agent (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
Is a |
Proguanil-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
Is a |
Chloroquine-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
Is a |
Product containing proguanil hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chloroquine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
chlorhydrate de proguanil |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Biguanide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Proguanil |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
Is a |
Product containing chloroquine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
chlorhydrate de proguanil |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chloroquine phosphate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|